Premium
Management of treatment resistant schizophrenia in medium secure care
Author(s) -
Lopes Antonio T,
Gilluley Paul,
Veisi Mehdi,
Patel Shamir,
Sukhwal Seema,
Dow Joanna,
Bendi Nagendra
Publication year - 2014
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.349
Subject(s) - clozapine , schizophrenia (object oriented programming) , medicine , psychiatry , intensive care medicine
Thirty‐one percent of patients within a male medium secure unit (MMSU) were identified with treatment resistant schizophrenia. Almost half of these patients had not received clozapine treatment at least once during the course of their treatment history. The authors recommend that early identification of these patients and the appropriate use of therapeutic treatments, including clozapine, could lead to better outcomes for patients and significant cost savings for the NHS.